A clinical research consortium sponsored by NIAID and JDRF
Researchers, doctors and patients
Home

Publications

Article

Circulating angiopoietin-2 as a biomarker in ANCA-associated Vasculitis.

PLoS ONE 7:e30197, 2012.

Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Hoffman GS, Ikle D, Kallenberg CGM, Langford CA, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Merkel PA, Kumpers P, Lukasz A, Carette S, Khalidi NA, Haubitz M

[PubMed] [Reprint] [Citation View]
Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Hoffman GS, Ikle D, Kallenberg CGM, Langford CA, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Merkel PA, Kumpers P, Lukasz A, Carette S, Khalidi NA, Haubitz M. Circulating angiopoietin-2 as a biomarker in ANCA-associated Vasculitis. PLoS ONE 7:e30197, 2012..

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.

JAMA 307: 283-293, 2012.

Feng S, Lobritto SJ, Demetris AJ, Rosenthal P, Philogene MC, Ikle D, Turka LA, Ekong UD, Roberts JP, Alonso EM, Poole KM, Bridges ND, Tchao NK.

[PubMed] [Reprint] [Citation View]
Feng S, Lobritto SJ, Demetris AJ, Rosenthal P, Philogene MC, Ikle D, Turka LA, Ekong UD, Roberts JP, Alonso EM, Poole KM, Bridges ND, Tchao NK.. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 307: 283-293, 2012..

Acute Renal Endothelial Injury During Marrow Recovery in a Cohort of Combined Kidney and Bone Marrow Allografts.

Am J Transplantation, June 2011

Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffer FI, LoCascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB

[PubMed] [Reprint] [Citation View]
Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffer FI, LoCascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB. Acute Renal Endothelial Injury During Marrow Recovery in a Cohort of Combined Kidney and Bone Marrow Allografts. Am J Transplantation, June 2011.

Challenges in the pursuit of immune tolerance.

Immunol Rev, 241:49-62, 2011

Nepom GT, St. Clair EW, Turka LA

[PubMed] [Reprint] [Citation View]
Nepom GT, St. Clair EW, Turka LA. Challenges in the pursuit of immune tolerance. Immunol Rev, 241:49-62, 2011.

Circulating markers of vascular injury and angiogenesis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Arthritis Rheum 63: 3988-3997, 2011

Monach PA, Tomasson G, Specks U, Stone JH, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CGM, Langford CA, Mueller M, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Merkel PA., Cuthbertson D, Gu Y-Z, Snyder RD

[PubMed] [Reprint] [Citation View]
Monach PA, Tomasson G, Specks U, Stone JH, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CGM, Langford CA, Mueller M, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Merkel PA., Cuthbertson D, Gu Y-Z, Snyder RD. Circulating markers of vascular injury and angiogenesis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheum 63: 3988-3997, 2011.

Design of the Rituximab in ANCA-associated Vasculitis (RAVE) Trial.

The Open Arthritis Journal: 4, 1-18, 2011

Specks U, Merkel PA, Hoffman GS, Langford CA, Spiera R, Seo P, Kallenberg CGM, St. Clair EW, Ding L, Webber L, Mokhtarani M, Tchao NK, Sayre PH, Seyfert-Margolis V, Ikle D, Brunetta P, Mueller M, Zhang D, Sejismundo L, Stone JH.

[Reprint] [Citation View]
Specks U, Merkel PA, Hoffman GS, Langford CA, Spiera R, Seo P, Kallenberg CGM, St. Clair EW, Ding L, Webber L, Mokhtarani M, Tchao NK, Sayre PH, Seyfert-Margolis V, Ikle D, Brunetta P, Mueller M, Zhang D, Sejismundo L, Stone JH.. Design of the Rituximab in ANCA-associated Vasculitis (RAVE) Trial. The Open Arthritis Journal: 4, 1-18, 2011.

Donor-specific indirect pathway analysis reveals a B-cell independent signature which reflects outcomes in kidney transplant recipients.

Am J Transplant 2011

Haynes LD, Jankowska-Gan E, Hernandez-Fuentes MP, Lechler RI, Seyfert-Margolis V, Turka LA, Newell KA, Burlingham WJ, Sheka A, Keller MR

[PubMed] [Reprint] [Citation View]
Haynes LD, Jankowska-Gan E, Hernandez-Fuentes MP, Lechler RI, Seyfert-Margolis V, Turka LA, Newell KA, Burlingham WJ, Sheka A, Keller MR. Donor-specific indirect pathway analysis reveals a B-cell independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant 2011.

Increased frequencies of myelin oligodendrocyte glycoprotein/MHC Class II-binding CD4 cells in patients with multiple sclerosis.

J Immunol June 2011

Seyfert-Margolis V, Nepom GT, Raddassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Kwok WW, Hafler DA

[PubMed] [Reprint] [Citation View]
Seyfert-Margolis V, Nepom GT, Raddassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Kwok WW, Hafler DA. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC Class II-binding CD4 cells in patients with multiple sclerosis. J Immunol June 2011.

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

J Allergy Clin Immunol 127, Number 2: 509-516, 2011

James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Frances JN, Jacobson MR, Kimber I, Till SJ, Durham, SR

[PubMed] [Reprint] [Citation View]
James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Frances JN, Jacobson MR, Kimber I, Till SJ, Durham, SR. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 127, Number 2: 509-516, 2011.

Regulatory cells and cell signatures in clinical transplantation tolerance.

Curr Opin Immunol. 23: 655-659, 2011

Turka LA, Newell KA, Phippard D

[PubMed] [Reprint] [Citation View]
Turka LA, Newell KA, Phippard D. Regulatory cells and cell signatures in clinical transplantation tolerance. Curr Opin Immunol. 23: 655-659, 2011.

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.

J Autoimmun. 34: 408-415, 2010

Matthews JB, Tchao N, Sayre P, Bianchine P, Orban T, Farkas K, Jalahej H, Kis J, Treszl A, Falk B, Reijonen H, Wolfsdorf J, Ricker A

[PubMed] [Reprint] [Citation View]
Matthews JB, Tchao N, Sayre P, Bianchine P, Orban T, Farkas K, Jalahej H, Kis J, Treszl A, Falk B, Reijonen H, Wolfsdorf J, Ricker A. Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J Autoimmun. 34: 408-415, 2010.

Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia.

Curr Opin Organ Transplant 15: 441-448, 2010

Turka LA, Bluestone JA, Wood K

[PubMed] [Citation View]
Turka LA, Bluestone JA, Wood K. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia. Curr Opin Organ Transplant 15: 441-448, 2010.

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group.

Clin. Exp. Immunol. 160: 176-184, 2010

Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M, ITN/JDRF Type 1 Diabetes Combination Therapy Assessment Group

[Reprint] [Citation View]
Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M, ITN/JDRF Type 1 Diabetes Combination Therapy Assessment Group. Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin. Exp. Immunol. 160: 176-184, 2010.

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

J Clin Invest 120: 1848-1861, 2010

Bourcier K, Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Sharif A, Krajewska M, Lord GM

[PubMed] [Reprint] [Citation View]
Bourcier K, Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Sharif A, Krajewska M, Lord GM. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 120: 1848-1861, 2010.

Identification of a B cell signature associated with renal transplant tolerance in humans.

J Clin Invest 120: 1836-1847, 2010

Newell KA, Asare A, Bourcier K, Burlingham WJ, Turka LA, Kirk AD, Gisler TD, Suthanthiran M, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Seyfert-Margolis VL

[PubMed] [Reprint] [Citation View]
Newell KA, Asare A, Bourcier K, Burlingham WJ, Turka LA, Kirk AD, Gisler TD, Suthanthiran M, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Seyfert-Margolis VL. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120: 1836-1847, 2010.

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.

Transplantation. 90: 1607-1615, 2010.

LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman Sl, Spitzer TR, Tolkoff-Rubin N, Cosimi BA, Sachs DH, Sykes M

[PubMed] [Citation View]
LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman Sl, Spitzer TR, Tolkoff-Rubin N, Cosimi BA, Sachs DH, Sykes M. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation. 90: 1607-1615, 2010..

Per-channel basis normalization methods for flow cytometry data.

Cytometry A 77:121-31, 2010

Seyfert-Margolis V, Bourcier K, Asare A, Hahne F, Khodabakhshi AH, Bashashati A, Wong CJ, Gascoyne RD, Weng AP, Lumley T, Gentleman R, Brinkman RR

[PubMed] [Reprint] [Citation View]
Seyfert-Margolis V, Bourcier K, Asare A, Hahne F, Khodabakhshi AH, Bashashati A, Wong CJ, Gascoyne RD, Weng AP, Lumley T, Gentleman R, Brinkman RR. Per-channel basis normalization methods for flow cytometry data. Cytometry A 77:121-31, 2010.

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.

New Eng J Med 363: 221-232, 2010

St. Clair EW, Ikle D, Seyfert-Margolis V, Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CGM, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geet

[PubMed] [Reprint] [Citation View]
St. Clair EW, Ikle D, Seyfert-Margolis V, Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CGM, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geet. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. New Eng J Med 363: 221-232, 2010.

Ten years of the Immune Tolerance Network: An integrated clinical research organization.

Sci Transl Med 2, 19cm7, 2010

Turka LA, Bluestone JA, Krensky AM, Rotrosen D, Matthews JB

[PubMed] [Reprint] [Citation View]
Turka LA, Bluestone JA, Krensky AM, Rotrosen D, Matthews JB. Ten years of the Immune Tolerance Network: An integrated clinical research organization. Sci Transl Med 2, 19cm7, 2010.

The Immune Tolerance Network at 10 years: Tolerance research at the bedside.

Nature Reviews Immunology 10: 797-803, 2010

Bluestone JA, Nepom GT, Rotrosen D, St. Clair EW, Turka LA, Auchincloss H

[PubMed] [Reprint] [Citation View]
Bluestone JA, Nepom GT, Rotrosen D, St. Clair EW, Turka LA, Auchincloss H. The Immune Tolerance Network at 10 years: Tolerance research at the bedside. Nature Reviews Immunology 10: 797-803, 2010.

B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Am J Transplant 9: 2126-35, 2009

Wong W, Saidman Sl, Chittenden M, Shaffer J, Tolkoff-Rubin N, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Porcheray F, De Vito J, Girouard TC, Dey BR, Zorn E

[PubMed] [Reprint] [Citation View]
Wong W, Saidman Sl, Chittenden M, Shaffer J, Tolkoff-Rubin N, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Porcheray F, De Vito J, Girouard TC, Dey BR, Zorn E. B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant 9: 2126-35, 2009.

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

American Journal of Transplantation 9: 1087-1098, 2009.

Knechtle SJ, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW, Pascual J, Bloom DD, Kwun J

[PubMed] [Reprint] [Citation View]
Knechtle SJ, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW, Pascual J, Bloom DD, Kwun J. Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. American Journal of Transplantation 9: 1087-1098, 2009..

Murine high specificity/sensitivity competitive europium insulin autoantibody assay.

Diabetes Technol Ther 11:227-33, 2009

Miao D, Yu L, Eisenbarth GS, Babaya N, Liu E, Li M

[PubMed] [Reprint] [Citation View]
Miao D, Yu L, Eisenbarth GS, Babaya N, Liu E, Li M. Murine high specificity/sensitivity competitive europium insulin autoantibody assay. Diabetes Technol Ther 11:227-33, 2009.

Power enhancement via multivariate outlier testing with gene expression arrays.

Bioinformatics 25: 48-53, 2009

Asare A, Gao Z, Seyfert-Margolis V, Carey VJ, Wang R

[PubMed] [Reprint] [Citation View]
Asare A, Gao Z, Seyfert-Margolis V, Carey VJ, Wang R. Power enhancement via multivariate outlier testing with gene expression arrays. Bioinformatics 25: 48-53, 2009.

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

BMC Immunol 10:52, 2009

Bourcier K, Seyfert-Margolis V, de Jager W, Rijkers GT, Prakken BJ

[PubMed] [Reprint] [Citation View]
Bourcier K, Seyfert-Margolis V, de Jager W, Rijkers GT, Prakken BJ. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52, 2009.

Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies.

Biomedical Engineering Systems and Technologies, Springer Berlin Heidelberg, Fred A, Filipe J, Gamboa H, Editors, pp 520-530, 2009

Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK

[Reprint] [Citation View]
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK. Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies. Biomedical Engineering Systems and Technologies, Springer Berlin Heidelberg, Fred A, Filipe J, Gamboa H, Editors, pp 520-530, 2009.

Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.

J Clin Endocrinol Metab 94:504-10, 2009

Yu L, Miao D, Eisenbarth GS, Yu J, Steck AK, Babu S, McFann K, Hutton J, Klingensmith G

[PubMed] [Reprint] [Citation View]
Yu L, Miao D, Eisenbarth GS, Yu J, Steck AK, Babu S, McFann K, Hutton J, Klingensmith G. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab 94:504-10, 2009.

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years.

Clin Immunol 132: 166-173, 2009

Herold KC, Greenbaum C, Sayre P, Bianchine P, Seyfert-Margolis V, Bourcier K, Gitelman S, Puck J, Hagopian W, Gottlieb P, Wong E, Bluestone JA; Immune Tolerance Network ITN007AI Study Group

[PubMed] [Reprint] [Citation View]
Herold KC, Greenbaum C, Sayre P, Bianchine P, Seyfert-Margolis V, Bourcier K, Gitelman S, Puck J, Hagopian W, Gottlieb P, Wong E, Bluestone JA; Immune Tolerance Network ITN007AI Study Group. Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years. Clin Immunol 132: 166-173, 2009.

Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients.

Cytometry B Clin Cytom 76B: 69-78, 2009

Grant J, Bourcier K, Wallace S, Seyfert-Margolis V, Pan D, Conway A, Wallace PK

[PubMed] [Reprint] [Citation View]
Grant J, Bourcier K, Wallace S, Seyfert-Margolis V, Pan D, Conway A, Wallace PK. Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients. Cytometry B Clin Cytom 76B: 69-78, 2009.

CTLA4Ig treatment in patients with multiple sclerosis: An open-label, phase 1 clinical trial.

Neurology 71: 917-924, 2008

Bourcier K, Hafler DA, Guttmann CRG, Viglietta V, Buckle GJ, Healy B, Weiner HL, Egorova S, Rusche JR, Khoury SJ

[PubMed] [Reprint] [Citation View]
Bourcier K, Hafler DA, Guttmann CRG, Viglietta V, Buckle GJ, Healy B, Weiner HL, Egorova S, Rusche JR, Khoury SJ. CTLA4Ig treatment in patients with multiple sclerosis: An open-label, phase 1 clinical trial. Neurology 71: 917-924, 2008.

Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation.

BMC Genomics 9:474, 2008

Asare AL, Gao Z, Wang R, Raddassi K, Bourcier K, Seyfert-Margolis V, Kolchinsky SA

[PubMed] [Reprint] [Citation View]
Asare AL, Gao Z, Wang R, Raddassi K, Bourcier K, Seyfert-Margolis V, Kolchinsky SA. Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation. BMC Genomics 9:474, 2008.

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.

J Allergy Clin Immunol 121:1120-1125, 2008

Francis JN, James LK, Durham SR, Till SJ, Paraskevopoulos G, Wong C, Calderon MA

[PubMed] [Reprint] [Citation View]
Francis JN, James LK, Durham SR, Till SJ, Paraskevopoulos G, Wong C, Calderon MA. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 121:1120-1125, 2008.

HLA-Mismatched renal transplantation without maintenance immunosuppression.

N Engl J Med 358: 353-61, 2008.

Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman Sl, Shaffer J, Preffer FI, Dey B, Ko DSC, Wong W, Colvin RB, Sykes M, Sachs DH, Ding R, Sharma V, Fishman JA, Hertl M, Goes NB, Williams WW

[PubMed] [Reprint] [Citation View]
Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman Sl, Shaffer J, Preffer FI, Dey B, Ko DSC, Wong W, Colvin RB, Sykes M, Sachs DH, Ding R, Sharma V, Fishman JA, Hertl M, Goes NB, Williams WW. HLA-Mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358: 353-61, 2008..

Knowledge-data integration for temporal reasoning in a clinical trial system.

Int J Med Inform. 78:S77-85, 2009

O'Connor MJ, Shankar RD, Parrish DB, Das AK

[PubMed] [Reprint] [Citation View]
O'Connor MJ, Shankar RD, Parrish DB, Das AK. Knowledge-data integration for temporal reasoning in a clinical trial system. Int J Med Inform. 78:S77-85, 2009.

Marking a path to transplant tolerance [Commentary].

J Clin Invest 118:2684-6, 2008

Seyfert-Margolis V, Turka LJ

[PubMed] [Reprint] [Citation View]
Seyfert-Margolis V, Turka LJ. Marking a path to transplant tolerance [Commentary]. J Clin Invest 118:2684-6, 2008.

MIFlowCyt: the minimum information about a Flow Cytometry Experiment.

Cytometry A 73:926-30, 2008

Kong M, Qian Y, Smith C, Scheuermann RH, Brinkman RR, Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Selvaraj B, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R; International Society for Advancement of Cytometry Data Standards Task Force

[PubMed] [Reprint] [Citation View]
Kong M, Qian Y, Smith C, Scheuermann RH, Brinkman RR, Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Selvaraj B, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R; International Society for Advancement of Cytometry Data Standards Task Force. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A 73:926-30, 2008.

Retrospective tissue typing of the kidney donor from recipient urine.

Kidney Int 74:952-5, 2008

Sergeant R, Lechler RI, Hernandez-Fuentes MP, Srikantha M, Khan T, Davey N, Warrens AN

[PubMed] [Reprint] [Citation View]
Sergeant R, Lechler RI, Hernandez-Fuentes MP, Srikantha M, Khan T, Davey N, Warrens AN. Retrospective tissue typing of the kidney donor from recipient urine. Kidney Int 74:952-5, 2008.

Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.

Immunology 123: 66-78, 2008.

Vandenbark AA, Culbertson NE, Mass M, Bartholomew RM, Huan J, Agotsch M, LaTocha D, Yadav V, Whitham R, Lovera J, Milano J, Theofan G, Chou YK, Offner H, Bourdette DN

[PubMed] [Reprint] [Citation View]
Vandenbark AA, Culbertson NE, Mass M, Bartholomew RM, Huan J, Agotsch M, LaTocha D, Yadav V, Whitham R, Lovera J, Milano J, Theofan G, Chou YK, Offner H, Bourdette DN. Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology 123: 66-78, 2008..

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Clin Immunol 125:131-137, 2007

Barker JM, Babu S, Zhang L, Su M, Stenerson M, Cheng M et al

[PubMed] [Reprint] [Citation View]
Barker JM, Babu S, Zhang L, Su M, Stenerson M, Cheng M et al. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol 125:131-137, 2007.

Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.

Clin Immunol 125:120-126, 2007

Liu E, Eisenbarth GS

[PubMed] [Reprint] [Citation View]
Liu E, Eisenbarth GS. Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol 125:120-126, 2007.

Allorecognition and the alloresponse: Clinical implications.

Tiss Antigens 69:545-56, 2007

Lechler RI, Hernandez-Fuentes MP, Afzali B

[PubMed] [Reprint] [Citation View]
Lechler RI, Hernandez-Fuentes MP, Afzali B. Allorecognition and the alloresponse: Clinical implications. Tiss Antigens 69:545-56, 2007.

Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.

J Rheumatol 34:734-739, 2007

Yu L, Wang J, Eisenbarth GS, O'Dell JR, Oates J, Arend WP

[PubMed] [Reprint] [Citation View]
Yu L, Wang J, Eisenbarth GS, O'Dell JR, Oates J, Arend WP. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. J Rheumatol 34:734-739, 2007.

Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.

J Allergy Clin Immunol 120: 688-95, 2007.

Seyfert-Margolis V, Casale TB, Klunker S, Saggar LR, Asare AL, Durham SR, Francis JN, Immune Tolerance Network Group

[PubMed] [Reprint] [Citation View]
Seyfert-Margolis V, Casale TB, Klunker S, Saggar LR, Asare AL, Durham SR, Francis JN, Immune Tolerance Network Group. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol 120: 688-95, 2007..

Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1.

J Immunol 179: 3443-51, 2007.

Jankowska-Gan E, Xu Q, Burlingham WJ, Derks RA

[PubMed] [Reprint] [Citation View]
Jankowska-Gan E, Xu Q, Burlingham WJ, Derks RA. Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J Immunol 179: 3443-51, 2007..

HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population.

Diabetes 56:2405-2409, 2007

Aly TA, Babu SR, Fernando MS, Yu L, Baschal EE, Miao D et al

[PubMed] [Reprint] [Citation View]
Aly TA, Babu SR, Fernando MS, Yu L, Baschal EE, Miao D et al. HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population. Diabetes 56:2405-2409, 2007.

Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance.

J Immunol 178: 3983-3995, 2007.

Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, Vanbuskirk AM, Torrealba JR, Burlingham WJ

[PubMed] [Reprint] [Citation View]
Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, Vanbuskirk AM, Torrealba JR, Burlingham WJ. Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance. J Immunol 178: 3983-3995, 2007..

New reagents on the horizon for immune tolerance.

Ann Rev Medicine 58:329–46, 2007

St. Clair EW, Turka LA, Matthews JB, Eisenbarth GS, Bluestone JA, Saxon A, Sayegh MH

[PubMed] [Reprint] [Citation View]
St. Clair EW, Turka LA, Matthews JB, Eisenbarth GS, Bluestone JA, Saxon A, Sayegh MH. New reagents on the horizon for immune tolerance. Ann Rev Medicine 58:329–46, 2007.

Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity.

J Clin Endocrinol Metab 92:88-92, 2007

Miao D, Babu S, Yu J, Klingensmith G, Eisenbarth GS, Yu L, Wang J, Barker J, Rewers M

[PubMed] [Reprint] [Citation View]
Miao D, Babu S, Yu J, Klingensmith G, Eisenbarth GS, Yu L, Wang J, Barker J, Rewers M. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88-92, 2007.

Role of autoantibodies in type 1 diabetes.

Front Biosci 12:1889-1898, 2007

Miao D, Yu L, Eisenbarth GS

[PubMed] [Reprint] [Citation View]
Miao D, Yu L, Eisenbarth GS. Role of autoantibodies in type 1 diabetes. Front Biosci 12:1889-1898, 2007.

Trivalent T cell receptor peptide vaccine for treatment of multiple sclerosis targets predominant V genes widely implicated in autoimmune diseases and allergy.

In: Immune Regulation and Immunotherapy in Autoimmune Disease. Zhang J, ed. Springer Life Sciences, pp 369-408, 2007.

Vandenbark AA, Culbertson NE

[PubMed] [Citation View]
Vandenbark AA, Culbertson NE. Trivalent T cell receptor peptide vaccine for treatment of multiple sclerosis targets predominant V genes widely implicated in autoimmune diseases and allergy. In: Immune Regulation and Immunotherapy in Autoimmune Disease. Zhang J, ed. Springer Life Sciences, pp 369-408, 2007..
Download Sitation